학술논문

CA209-9DX: phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
Document Type
Journal
Source
ANNALS OF ONCOLOGY; OCT 2018, 29 2p. Supplement: 8
Subject
Language
English
ISSN
15698041